Avinger Inc AVGR shares are trading higher Tuesday, adding to outsized gains from Monday. Here's a look at what's going on.
What To Know: On Monday, Avinger shares soared 46.8% to $6.07 after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device.
The commercial-stage medical device company said it conducted a limited launch prior to commercialization that showed successful implementation of new design features, safety, efficacy and product reliability.
"This device represents one of the most significant advancements in Avinger's image-guided technologies for the treatment of peripheral artery disease," said Jaafer Golzar, chief medical officer of Avinger.
After the close on Monday, a new regulatory filing showed that Avinger decided to increase the available amount for sale under its previously disclosed at the market offering up to an additional aggregate offering price of $2,133,181.
Avinger shares are moving on very high volume. The stock has been trending across social platforms this week. It was among the top trending tickers on Stocktwits at last check.
See Also: Apogee Q2: Earnings Beat, Margins Expansion, Raised EPS Outlook & More
AVGR Price Action: Avinger shares were up 51.4% at $9.20 Tuesday morning after rallying more than 46% on Monday, per Benzinga Pro.
Photo: Lorenzo Cafaro from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.